DISCOVID Trademark
Trademark Overview
On Wednesday, July 1, 2020, a trademark application was filed for DISCOVID with the United States Patent and Trademark Office. The USPTO has given the DISCOVID trademark a serial number of 90030341. The federal status of this trademark filing is REGISTERED as of Tuesday, May 25, 2021. This trademark is owned by Antagen Biosciences, Inc.. The DISCOVID trademark is filed in the Pharmaceutical Products category with the following description:
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, COVID-19 or coronavirus infection; Diagnostic reagents for medicinal use; Diagnostic biomarker reagents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Reagents and media for medical and veterinary diagnostic purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; all the foregoing goods for detecting and preventing the transmission of the coronavirus
General Information
| Serial Number | 90030341 |
| Word Mark | DISCOVID |
| Filing Date | Wednesday, July 1, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 25, 2021 |
| Registration Number | 6359994 |
| Registration Date | Tuesday, May 25, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 9, 2021 |
Trademark Statements
| Goods and Services | Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, COVID-19 or coronavirus infection; Diagnostic reagents for medicinal use; Diagnostic biomarker reagents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Reagents and media for medical and veterinary diagnostic purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; all the foregoing goods for detecting and preventing the transmission of the coronavirus |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 29, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Sunday, May 31, 2020 |
| First Use In Commerce Date | Sunday, May 31, 2020 |
Trademark Owner History
| Party Name | Antagen Biosciences, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02118
US |
| Party Name | Antagen Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02118
US |
| Party Name | Antagen Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02118
US |
Trademark Events
| Event Date | Event Description |
| Saturday, July 4, 2020 | NEW APPLICATION ENTERED |
| Wednesday, July 29, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 22, 2021 | ASSIGNED TO EXAMINER |
| Friday, January 29, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, January 29, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, January 29, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, January 29, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, January 29, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 17, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 9, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 9, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 25, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 25, 2026 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
